Pentoxifylline decreases serum levels of tumor necrosis factor alpha, interleukin 6 and C-reactive protein in hemodialysis patients: results of a randomized double-blind, controlled clinical trial. [electronic resource]
Producer: 20121207Description: 2023-8 p. digitalISSN:- 1460-2385
- Adult
- Anti-Inflammatory Agents -- therapeutic use
- Biomarkers -- blood
- C-Reactive Protein -- metabolism
- Double-Blind Method
- Female
- Humans
- Inflammation -- prevention & control
- Interleukin-6 -- blood
- Kidney Failure, Chronic -- blood
- Male
- Middle Aged
- Pentoxifylline -- therapeutic use
- Renal Dialysis
- Treatment Outcome
- Tumor Necrosis Factor-alpha -- blood
No physical items for this record
Publication Type: Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.